| 05/07/2024 12:00 |
Daiichi Sankyo Announces Status Relating to Acquisition of Own Shares |
| 04/25/2024 13:00 |
FY2023 Financial Results Presentation |
| 04/25/2024 13:00 |
Reference Data |
| 04/25/2024 13:00 |
Consolidated Financial Results for Year Ended March 31, 2024 |
| 04/25/2024 13:00 |
Daiichi Sankyo Announces Determination of Matters Relating to Acquisition and Cancellation of Own Shares |
| 03/19/2024 15:00 |
Partial Amendments to Trust-type Share Grant System for Officers and Employees of its U.S. Subsidiaries |
| 01/31/2024 13:00 |
FY2023 Q3 Financial Results Presentation |
| 01/31/2024 13:00 |
Reference Data |
| 01/31/2024 13:00 |
Consolidated Financial Results for the First Nine Months of the Year Ending March 31,2024 |
| 01/31/2024 13:00 |
Announcement regarding Revision of the Annual Dividend Forecast for the Year Ending March 31 2024 |
| 12/22/2023 12:00 |
Daiichi Sankyo Corporate Governance Report |
| 12/11/2023 17:20 |
Daiichi Sankyo's "R&D Day 2023" |
| 12/06/2023 08:30 |
Plexxikon Obtains 182 Million USD Settlement Resolving U.S. Patent Infringement Lawsuit against Novartis |
| 11/17/2023 12:00 |
Daiichi Sankyo Appeals Amended Texas Court Judgement in Patent Dispute with Seagen |
| 10/31/2023 15:00 |
Notice for Merger of Daiichi Sankyo with Its Wholly Owned Subsidiaries |
| 10/31/2023 13:00 |
Announcement regarding Revision of the Annual Dividend Forecast for the Year Ending March 31, 2024 |
| 10/31/2023 13:00 |
FY2023 Q2 Financial Results Presentation |
| 10/31/2023 13:00 |
Reference Data |
| 10/31/2023 13:00 |
Consolidated Financial Results for the First Six Months of the Year Ending March 31,2024 |
| 10/20/2023 08:30 |
Daiichi Sankyo and Merck & Co., Inc., Rahway, N.J., USA Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd A |
| 10/18/2023 17:00 |
Texas District Court Issues Amended Final Judgment in Patent Dispute between Daiichi Sankyo and Seagen |
| 07/31/2023 13:00 |
FY2023 Q1 Financial Results Presentation |
| 07/31/2023 13:00 |
Reference Data |
| 07/31/2023 13:00 |
Consolidated Financial Results for the First Three Months of the Year Ending March 31,2024 |
| 07/18/2023 15:00 |
Daiichi Sankyo Announces Completion of Payment Concerning Disposal of Treasury Shares as Restricted Share-Based Compensation |
| 06/20/2023 15:05 |
Daiichi Sankyo Corporate Governance Report |
| 06/19/2023 17:00 |
Daiichi Sankyo Announces Disposal of Treasury Shares as Restricted Share-Based Compensation |
| 05/22/2023 08:00 |
Other Matters regarding Electronic Provision Measure |
| 05/22/2023 08:00 |
18th Report to Shareholders |
| 05/22/2023 08:00 |
CONVOCATION NOTICE OF THE 18TH ORDINARY GENERAL SHAREHOLDERS MEETING |
| 05/16/2023 15:00 |
Stock Transfer of DAIICHI SANKYO ESPHA CO., LTD. (Change in Consolidated Subsidiary) |
| 05/16/2023 13:00 |
Partial Amendments to Trust-type Share Grant System for Officers and Employees of its U.S. Subsidiaries |
| 05/16/2023 13:00 |
Daiichi Sankyo Announces Appointments of Directors and Audit & Supervisory Board Members |
